GE Healthcare unveiled new mammogram technology called Senographe Pristina Dueta this week at RSNA2017 underway at McCormick Place in Chicago.
RSNA is always chockablock with all manner of image technology, but this one seems bound to draw attention especially from the women in the crowd.
According to GE Healthcare executives, four out of five patients said the patient-assisted compression technology, called Senographe Pristina Dueta, made their mammograms more comfortable and more than half said it led to less anxiety
The technology is billed as industry-first patient-assisted mammography device that puts women in control of their own mammograms.
It was designed by women for women, noted GE Healthcare executives. It features a wireless remote control that allows patients to manage their own compression, under the supervision of a technologist, during the exam.
Clinical evidence used in the FDA evaluation and clearance of Pristina Dueta shows the use of the device does not compromise image quality or increase exam time.
For women with dense breast tissue, supplemental screening may be recommended. The Invenia ABUS (Automated Breast Ultrasound System) is proven to increase invasive cancer detection by 55 percent and is the only FDA-approved ultrasound system for dense breast tissue screening when used in addition to mammography, according to GE Healthcare.
GE Healthcare also introduced SenoBright HD, which it calls a next-generation Contrast Enhanced Spectral Mammography diagnostic exam intended for patients who have just had an inconclusive mammogram or ultrasound or are at high risk of breast cancer. SenoBright HD exams are performed at the same time, the same location with the same mammography equipment – Senographe Pristina – enabling the entire exam to take less than seven minutes.